Sunrise Mediworld Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 11-12-2024
- Paid Up Capital ₹ 2.50 M
as on 11-12-2024
- Company Age 8 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.00 M
as on 11-12-2024
- Revenue -7.22%
(FY 2019)
- Profit -20.12%
(FY 2019)
- Ebitda -14.71%
(FY 2019)
- Net Worth -542.95%
(FY 2019)
- Total Assets 24.50%
(FY 2019)
About Sunrise Mediworld
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹3.00 M.
Valay Solanki, Annapurnaba Gohil, Jayeshkumar Solanki, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230GJ2016PTC085991
- Company No.
085991
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Feb 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sunrise Mediworld?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayeshkumar Solanki  | Director | 05-Mar-2016 | Current |
| Valay Solanki | Director | 05-Mar-2016 | Current |
| Annapurnaba Gohil | Director | 08-Feb-2016 | Current |
| Ravindrasinh Gohil | Director | 08-Feb-2016 | Current |
Financial Performance of Sunrise Mediworld.
Sunrise Mediworld Private Limited, for the financial year ended 2019, experienced Minor drop in revenue, with a 7.22% decrease. The company also saw a substantial fall in profitability, with a 20.12% decrease in profit. The company's net worth observed a substantial decline by a decrease of 542.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sunrise Mediworld?
In 2019, Sunrise Mediworld had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vasudev Ginning & Pressing Private LimitedActive 12 years 10 monthsValay Solanki is a mutual person
- Orchid Mediservices And Research Private LimitedActive 14 years 8 months
Valay Solanki is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 07 Apr 2018 | ₹3.00 M | Open |
How Many Employees Work at Sunrise Mediworld?
Unlock and access historical data on people associated with Sunrise Mediworld, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sunrise Mediworld, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunrise Mediworld's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
